Author:
Liu Joyce F.,Gray Kathryn P.,Wright Alexi A.,Campos Susana,Konstantinopoulos Panagiotis A.,Peralta Ariana,MacNeill Kimberley,Morrissey Stephanie,Whalen Christin,Dillon Deborah,Matulonis Ursula A.
Funder
National Comprehensive Cancer Network
Subject
Obstetrics and Gynaecology,Oncology
Reference31 articles.
1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. 2018 Nov;68(6):394–424. PubMed PMID: 30207593.
2. Leath CA, 3rd, Monk BJ. Twenty-first century cervical cancer management: a historical perspective of the gynecologic oncology group/NRG oncology over the past twenty years. Gynecol. Oncol. 2018 Sep;150(3):391–7. PubMed PMID: 29954593. Pubmed Central PMCID: (6102091).
3. Improved survival with bevacizumab in advanced cervical cancer;Tewari;N. Engl. J. Med.,2014
4. Safety and efficacy of pembrolizumab in advanced, programmed death ligand 1-positive cervical cancer: results from the phase Ib KEYNOTE-028 trial;Frenel;Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology,2017
5. Pembrolizumab treatment of advanced cervical cancer: updated results from the phase 2 KEYNOTE-158 study;Chung;Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology,2018
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献